Welcome to Bjørgvin Therapeutics

API synthesis made simple—based in Bergen

A New Model for Resilient Pharmaceutical Production

We are building a new model for pharmaceutical production in Norway to help solve the global shortage of essential medicines. Using flow chemistry, we manufacture drugs faster, safer, and more sustainably than traditional batch processes.

Our goal is to establish modular, GMP-compliant production facilities that enable small-scale, on-demand manufacturing of critical medicines—both to revive discontinued drugs and to support the growing need for personalized treatments.

Innovation at the core

Flow chemistry

Continuous, precise, and easily scalable production

Essential and personalized medicines

Ensuring access to critical therapies

Sustainability

Reduced waste, solvent recycling, and lower energy use

Modular GMP facilities

Flexible units for local or regional production

Strategic impact

Positioning Norway as a frontrunner in resilient, green pharmaceutical manufacturing

Meet the Team

Bjørgvin Therapeutics Group brings together leading scientists, clinicians, and entrepreneurs with a shared mission to advance innovative chemistry and therapeutic development. With expertise spanning organic synthesis, process chemistry, biotechnology, and translational research, our team bridges the gap between discovery and scalable production.

From on-demand synthesis of complex APIs to early-stage drug development, we combine scientific creativity with industrial precision to accelerate innovation in health and life sciences—turning ideas into tangible, high-impact solutions.